Value of a Marker Lesion in Non-Muscle-Invasive Bladder Cancer Patients Treated with Interleukin-2 Instillations: A Randomized Controlled Multicentre Trial.

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)69-76
JournalUrologia Internationalis
Volume102
Issue number1
Early online date28 Sep 2018
DOIs
Publication statusPublished - Jan 2019

Cite this